drugset / Trial / NCT01850160

Efficacy/Safety Study of Valsartan and Chlorthalidone Conjugate Treatment Compared to Simple Treatment for Hypertension

NCT01850160

Phase 3 Completed 124 enrolled Farma de Colombia SA
RandomizedParallel-groupOpen-labelTreatment

Summary

This trial is aimed to assess the efficacy and safety of a fixed-dose combination therapy with Valsartan and Chlorthalidone, Vs Valsartan or Chlorthalidone alone for treatment of adult patients with diagnosis of arterial hypertension.

Timeline

Start
2013-04
Primary completion
2015-03
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorthalidone Other / unclassified 12.5 mg
Subject Valsartan Small molecule 80 mg

Indications